Published in
Esmo Open, Esmo Open, 6(6), p. 100328, 2021
DOI: 10.1016/j.esmoop.2021.100328
Links
Tools
Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study
Journal article published in 2021 by
J. Tabernero 
,
L. Velez,
T. L. Trevino,
A. Grothey ,
R. Yaeger ,
E. Van Cutsem ,
H. Wasan ,
J. Desai ,
F. Ciardiello ,
T. Yoshino ,
A. Gollerkeri ,
K. Maharry,
J. Christy-Bittel,
S. Kopetz
,
L. Velez,
T. L. Trevino,
A. Grothey ,
R. Yaeger ,
E. Van Cutsem ,
H. Wasan ,
J. Desai ,
F. Ciardiello ,
T. Yoshino ,
A. Gollerkeri ,
K. Maharry,
J. Christy-Bittel,
S. Kopetz
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 